Sári, Z.; Mikó, E.; Kovács, T.; Boratkó, A.; Ujlaki, G.; Jankó, L.; Kiss, B.; Uray, K.; Bai, P.
Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers 2020, 12, 2915.
https://doi.org/10.3390/cancers12102915
AMA Style
Sári Z, Mikó E, Kovács T, Boratkó A, Ujlaki G, Jankó L, Kiss B, Uray K, Bai P.
Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers. 2020; 12(10):2915.
https://doi.org/10.3390/cancers12102915
Chicago/Turabian Style
Sári, Zsanett, Edit Mikó, Tünde Kovács, Anita Boratkó, Gyula Ujlaki, Laura Jankó, Borbála Kiss, Karen Uray, and Péter Bai.
2020. "Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress" Cancers 12, no. 10: 2915.
https://doi.org/10.3390/cancers12102915
APA Style
Sári, Z., Mikó, E., Kovács, T., Boratkó, A., Ujlaki, G., Jankó, L., Kiss, B., Uray, K., & Bai, P.
(2020). Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers, 12(10), 2915.
https://doi.org/10.3390/cancers12102915